Merck & Co., Inc. (MRK)
NYSE · Healthcare
Merck & Co., Inc. EPS 2007–2025
Merck & Co., Inc. annual/quarterly eps history and growth rate from 2007 to 2026. Earnings per share (EPS) is a company's net profit divided by the number of diluted shares outstanding. Higher EPS generally indicates greater profitability.
- Merck & Co., Inc. eps for the quarter ending March 31, 2026 was $1.72, a 185.57% decrease year-over-year.
- Merck & Co., Inc. annual eps for 2025 was $7.28, a 8.01% increase from 2024.
- Merck & Co., Inc. annual eps for 2024 was $6.74, a 4714.29% increase from 2023.
- Merck & Co., Inc. annual eps for 2023 was $0.14, a 97.55% decrease from 2022.
- Merck & Co., Inc. annual eps for 2022 was $5.71.
EPS
ANNUAL · USD
QUARTERLY · USD
YEAR-OVER-YEAR GROWTH · %
Merck & Co. Inc. EPS — FAQ
Merck & Co. Inc. (MRK) eps over the last 14 years — annual and quarterly figures with year-over-year growth and charts.
What is Merck & Co. Inc.'s eps?
Merck & Co. Inc. (MRK) reported eps of $7.28 for fiscal 2025.
Where can I see MRK's eps history?
The chart and table above show Merck & Co. Inc.'s eps by year and by quarter, including the growth rate.